Role of Ranolazine in the Prevention and Treatment of Atrial Fibrillation in Patients with Left Ventricular Systolic Dysfunction: A Meta-Analysis of Randomized Clinical Trials

Background: Ranolazine has the potential to prevent atrial fibrillation (AF) and plays a role in rhythm control strategy for atrial fibrillation in various clinical settings. However, data on the use of ranolazine in patients with left ventricular (LV) systolic dysfunction are limited. The aims of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Leelapatana, Pattranee, Thongprayoon, Charat, Prasitlumkum, Narut, Vallabhajosyula, Saraschandra, Cheungpasitporn, Wisit, Chokesuwattanaskul, Ronpichai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167551/
https://www.ncbi.nlm.nih.gov/pubmed/33923428
http://dx.doi.org/10.3390/diseases9020031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167551/
https://www.ncbi.nlm.nih.gov/pubmed/33923428
http://dx.doi.org/10.3390/diseases9020031

Ejemplares similares